research use only

Methyl cellulose (Viscosity:100000mPa.s)

Cat.No.E2934

Methyl cellulose ( hydroxypropyl methylcellulose, hypromellose) viscosity: 100000 mPa.s., a soluble methylcellulose ether, is used as a thickening agent, binder, film former, and hydrophilic matrix material.
Jump to

Quality Control

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 454.51 Formula

CH4O.xUnspecified

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 9004-67-5 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-10-28)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05999630 RECRUITING
Nasolacrimal Duct Obstruction; Thyroid Cancer
Vanderbilt University Medical Center
2023-08-21 PHASE3
NCT07635849 NOT_YET_RECRUITING
Dry Eye Disease (DED)
Pokhara Academy of Health Sciences, Western Regional Hospital
2026-07 PHASE4
NCT07523412 NOT_YET_RECRUITING
Peri-implant Bone and Soft Tissues
Ain Shams University
2026-04-12 PHASE4
NCT07676084 RECRUITING
Dry Eye Disease (DED)
Andover Research Eye Institute
2026-06-03 PHASE4
NCT07300137 ENROLLING_BY_INVITATION
Second Degree Burns
Patel Hospital, Pakistan
2025-09-20
NCT06601101 RECRUITING
Keratoconus; Cornea Disease; Eye Diseases; Wound Heal
University of Campinas, Brazil
2024-08-01 PHASE3

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.